Did the human genome project affect research on Schizophrenia?

Area of Science:

• Genetics
• Psychiatry
• Genomic Medicine

Background:

• The Human Genome Project aimed to find genetic causes and treatments for diseases.
• Schizophrenia was a key target due to suspected genetic links and personal interests.
• Previous family, adoption, and twin studies suggested schizophrenia is a genetic disorder.

Purpose of the Study:

• To review the effectiveness of the Human Genome Project's approach to schizophrenia research.
• To assess the yield of genetic research investments in understanding schizophrenia.
• To determine if schizophrenia is strictly a genetic disorder.

Main Methods:

• Utilized linkage analysis, candidate gene studies, and genome-wide association studies (GWAS).
• Incorporated analysis of copy number variants and exome sequencing.
• Examined data from extensive genetic studies on schizophrenia.

Main Results:

• Failed to identify specific causal genes for schizophrenia despite extensive research.
• Identified nearly 300 single nucleotide polymorphisms (SNPs) associated with altered schizophrenia risk.
• Discovered rare variants increasing risk in a small subset of individuals.

Conclusions:

• Genetic risk factors play a role but do not solely cause schizophrenia.
• The current research paradigm, heavily reliant on genetics, has yielded limited clinical utility.
• A review of the National Institute of Mental Health's schizophrenia research portfolio is warranted.